BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Hansen BE, Peppelenbosch MP, De Man RA, Pan Q, Sprengers D. Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma. Oncotarget 2017;8:15193-204. [PMID: 28122352 DOI: 10.18632/oncotarget.14771] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Gnyawali B, Pusateri A, Nickerson A, Jalil S, Mumtaz K. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma. World J Gastroenterol 2022; 28(29): 3793-3802 [DOI: 10.3748/wjg.v28.i29.3793] [Reference Citation Analysis]
2 Hyams TC, Luo L, Hair B, Lee K, Lu Z, Seminara D. Machine Learning Approach to Facilitate Knowledge Synthesis at the Intersection of Liver Cancer, Epidemiology, and Health Disparities Research. JCO Clin Cancer Inform 2022;6:e2100129. [PMID: 35623021 DOI: 10.1200/CCI.21.00129] [Reference Citation Analysis]
3 Turse E, Aboona M, Charley E, Forlemu A, Bowie T, Bhattarai B, Chuang K, Nadir A. Factors Associated with Survival of Hepatocellular Carcinoma (HCC) Patients at a Safety Net Hospital in Arizona without On-Site Liver Transplant Program. JHC 2022;Volume 9:1-11. [DOI: 10.2147/jhc.s341690] [Reference Citation Analysis]
4 Huang DC, Fricker ZP, Alqahtani S, Tamim H, Saberi B, Bonder A. The influence of equitable access policies and socioeconomic factors on post-liver transplant survival. EClinicalMedicine 2021;41:101137. [PMID: 34585128 DOI: 10.1016/j.eclinm.2021.101137] [Reference Citation Analysis]
5 Madreseh E, Mahmoudi M, Nassiri-Toosi M, Baghfalaki T, Zeraati H. Post Liver Transplantation Survival and Related Prognostic Factors among Adult Recipients in Tehran Liver Transplant Center; 2002-2019. Arch Iran Med 2020;23:326-34. [PMID: 32383617 DOI: 10.34172/aim.2020.22] [Reference Citation Analysis]
6 Adler Jaffe S, Myers O, Meisner ALW, Wiggins CL, Hill DA, McDougall JA. Relationship between Insurance Type at Diagnosis and Hepatocellular Carcinoma Survival. Cancer Epidemiol Biomarkers Prev 2020;29:300-7. [PMID: 31796525 DOI: 10.1158/1055-9965.EPI-19-0902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu G, Wu J, Pan X, Liu B, Yao Z, Guo Y, Shi X, Ding Y. Racial disparities in alpha-fetoprotein testing and alpha-fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients. Cancer Med. 2019;8:6614-6623. [PMID: 31517445 DOI: 10.1002/cam4.2549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kuftinec GN, Levy R, Kieffer DA, Medici V. Hepatocellular Carcinoma and Associated Clinical Features in Latino and Caucasian Patients from a Single Center. Ann Hepatol 2019;18:177-86. [PMID: 31113588 DOI: 10.5604/01.3001.0012.7910] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Ma J, Siegel RL, Islami F, Jemal A. Temporal trends in liver cancer mortality by educational attainment in the United States, 2000-2015. Cancer 2019;125:2089-98. [PMID: 30957228 DOI: 10.1002/cncr.32023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang Z, Gu X, Thrift AP. Factors associated with favorable survival outcomes for Asians with hepatocellular carcinoma: A sequential matching cohort study. PLoS One 2019;14:e0214721. [PMID: 30943273 DOI: 10.1371/journal.pone.0214721] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
11 Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC. Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Journal of the American College of Surgeons 2019;228:245-54. [DOI: 10.1016/j.jamcollsurg.2018.11.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ren F, Zhang J, Gao Z, Zhu H, Chen X, Liu W, Xue Z, Gao W, Wu R, Lv Y, Hu L. Racial disparities in the survival time of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma between Chinese patients and patients of other racial groups: A population-based study from 2004 to 2013. Oncol Lett 2018;16:7102-16. [PMID: 30546445 DOI: 10.3892/ol.2018.9550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
13 Wu EM, Hernandez BY, Wong LL. Hepatocellular carcinoma in Micronesians, a growing Pacific Islander population in the U.S. Open J Gastroenterol 2018;8:85660. [PMID: 30079276 DOI: 10.4236/ojgas.2018.86025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Kim NG, Nguyen PP, Dang H, Kumari R, Garcia G, Esquivel CO, Nguyen MH. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015: Long-Term Survival in Patients With HCC. Cancer 2018;124:2588-98. [DOI: 10.1002/cncr.31373] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
15 Malek Hosseini SA, Nikeghbalian S, Salahi H, Kazemi K, Shemsaeifar A, Bahador A, Dehghani M, Imanieh MH, Tabrizi R, Lankarani KB. Evolution of Liver Transplantation Program in Shiraz, Iran. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.60745] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
16 Zhou H, Zhang Y, Wei X, Yang K, Tan W, Qiu Z, Li S, Chen Q, Song Y, Gao S. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study. Cancer Med 2017;6:2745-56. [PMID: 28980417 DOI: 10.1002/cam4.1220] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
17 Islami F, Miller KD, Siegel RL, Fedewa SA, Ward EM, Jemal A. Disparities in liver cancer occurrence in the United States by race/ethnicity and state: Liver Cancer in the United States. CA: A Cancer Journal for Clinicians 2017;67:273-89. [DOI: 10.3322/caac.21402] [Cited by in Crossref: 81] [Cited by in F6Publishing: 109] [Article Influence: 16.2] [Reference Citation Analysis]